PALISADE BIO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.91 USD | -4.84% |
|
-22.80% | -44.52% |
| May. 10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
| May. 07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.6M | - | - | - | - | - | |
| 63.85B | - | |||||
| 41.83B | ||||||
| 40.65B | ||||||
| 27.12B | ||||||
| 26.52B |
- Stock Market
- Equities
- SNCA Stock
- Charts Palisade Bio, Inc.
- Sector Chart
